Aimedis (new) 가격AIMX $0.008085

Aimedis (new) 대 KRW 차트
데이터 로딩 중
잠시만 기다려 주세요. 차트 데이터를 로드하는 중입니다.
Aimedis-new 통계
- 시가총액
- $2,692,361.19
- 거래량(24시간)
- $56,432.23
- 수량/시가총액(24시)
- 2.10%
- 유통 공급량
- 333,000,000 AIMX
- 총 공급량
- 588,000,000 AIMX
- 최대 공급량
- 600,000,000 AIMX
- 완전 희석 시가총액
- $4,851,101.24
스폰서
등급 · 2건의 기관 평가를 기반으로 이루어 집니다.
데이터 로딩 중
잠시만 기다려 주세요. 차트 데이터를 로드하는 중입니다.
Aimedis (new) 커뮤니티
Aimedis (new) 뉴스
Aimedis (new) 정보
등급 · 2건의 기관 평가를 기반으로 이루어 집니다.
Aimedis - an eHealth platform based on blockchain technology, which has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combines eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, emergency records and much more along with medical social media platform, eLearning, eTeaching and education, a unique medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for patients and healthcare professionals. Aimedis builds the world’s first medical metaverse and opens the world’s first virtual hospital chain in the metaverse while offering space to other hospitals, companies, universities and people.
The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities. The Aimedis NFTs are a revolutionary tool for medical data along with functionalities inside the Aimedis metaverse.
Aimedis (new) 시장
# | 거래 | 쌍 | 가격 | +2% 깊이 | -2% 깊이 | 거래량(24시간) | 거래량 % | 신뢰도 | 유동성 점수 | 업데이트 |
---|---|---|---|---|---|---|---|---|---|---|
사용 가능한 데이터 없음 |
Disclaimer: This page may contain affiliate links. CoinMarketCap may be compensated if you visit any affiliate links and you take certain actions such as signing up and transacting with these affiliate platforms. Please refer to Affiliate Disclosure.